Article info
PDFViewpoint
Implications of the HELIX trial for treating infants with hypoxic-ischaemic encephalopathy in low-to-middle-income countries
- Correspondence to Prof Alistair J Gunn, Department of Physiology, The University of Auckland, Auckland 1023, New Zealand; aj.gunn{at}auckland.ac.nz
Citation
Implications of the HELIX trial for treating infants with hypoxic-ischaemic encephalopathy in low-to-middle-income countries
Publication history
- Received December 20, 2021
- Accepted February 7, 2022
- First published February 21, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (18 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.